Aoxiang Pharmaceutical (603229.SH) has received the approval notification for the application for the listing of atorvastatin sodium active pharmaceutical ingredients.

Zhixing Finance and Economics APP News, Aoxiang Pharmaceutical (603229.SH) announced that recently, the company has received the "Approval Notice for the Market Application of Fluvastatin Sodium Active Pharmaceutical Ingredients" issued by the National Medical Products Administration.